Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19.
作者信息
Porres-Aguilar Mateo, Mukherjee Debabrata, Lazo-Langner Alejandro
机构信息
Division of Hospital Medicine, Department of Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX.
Division of Cardiovascular Diseases, Department of Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX.
出版信息
Chest. 2022 Jul;162(1):e69-e70. doi: 10.1016/j.chest.2022.03.038.
Abstract
摘要
相似文献
1
Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19.
Chest. 2022 Jul;162(1):e69-e70. doi: 10.1016/j.chest.2022.03.038.
2
Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond.
Clin Microbiol Infect. 2022 Sep;28(9):1184-1186. doi: 10.1016/j.cmi.2022.05.027. Epub 2022 May 29.
3
Late-onset of pulmonary embolism following hospitalization for COVID-19 despite thromboprophylaxis: a report of two cases.
Pan Afr Med J. 2021 Mar 1;38:226. doi: 10.11604/pamj.2021.38.226.28503. eCollection 2021.
4
In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
Thromb Res. 2021 Jul;203:82-84. doi: 10.1016/j.thromres.2021.04.026. Epub 2021 May 1.
5
Do lung cancer patients require routine anticoagulation treatment? A meta-analysis.
J Int Med Res. 2020 Jan;48(1):300060519896919. doi: 10.1177/0300060519896919.
6
Venous thromboembolism in hospitalized patients: an updated analysis of missed opportunities for thromboprophylaxis at a university-affiliated tertiary care center.
Vasc Med. 2014 Oct;19(5):385-91. doi: 10.1177/1358863X14543737. Epub 2014 Jul 29.
7
Identification of prophylaxis and treatment for hospitalized patients associated with venous thromboembolism.
Chin Med J (Engl). 2023 May 5;136(9):1111-1113. doi: 10.1097/CM9.0000000000002237.
8
Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era.
Semin Respir Crit Care Med. 2021 Apr;42(2):308-315. doi: 10.1055/s-0041-1723018. Epub 2021 Feb 6.
9
Prevention of venous thromboembolism in hospitalized patients with inflammatory bowel disease.
Inflamm Bowel Dis. 2013 Mar;19(3):669-71. doi: 10.1097/MIB.0b013e31827e7a0f.
10
Is Rivaroxaban Superior to Enoxaparin for Thromboprophylaxis in Hospitalized Patients of COVID-19?`.
J Assoc Physicians India. 2022 Sep;70(9):11-12.
引用本文的文献
1
Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies.
Vascular. 2024 Feb;32(1):220-225. doi: 10.1177/17085381221126235. Epub 2022 Sep 8.
本文引用的文献
1
Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report.
Chest. 2022 Jul;162(1):213-225. doi: 10.1016/j.chest.2022.02.006. Epub 2022 Feb 12.
2
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.
3
Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis.
J Thromb Haemost. 2021 Aug;19(8):1981-1989. doi: 10.1111/jth.15400. Epub 2021 Jun 20.
4
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
Chest. 2021 Mar;159(3):1182-1196. doi: 10.1016/j.chest.2020.11.005. Epub 2020 Nov 17.
5
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report.
Chest. 2020 Sep;158(3):1143-1163. doi: 10.1016/j.chest.2020.05.559. Epub 2020 Jun 2.
Zotero 插件